Newsfile Corp
02 Apr 2026, 12:00 UTC · 33w ago
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
Impact · against what's priced in
Elite Pharmaceuticals is expanding its niche generic portfolio with the launch of methadone hydrochloride tablets. While this creates a new revenue stream, the addressable market is relatively small at $22 million in annual retail sales.
- ELTP+0.30
No priced-in read yet
- In context
The launch of generic methadone hydrochloride 5 mg and 10 mg tablets adds a new product to the company's portfolio, targeting a retail market valued at approximately $22 million.
Read from the article alone

Search tags




